首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Improving outcome of CAPD: twenty-five years' experience in a single korean center.
【24h】

Improving outcome of CAPD: twenty-five years' experience in a single korean center.

机译:改善CAPD的效果:在单个韩国中心拥有25年的工作经验。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Continuous ambulatory peritoneal dialysis (CAPD) is an established treatment for end-stage renal disease (ESRD). We investigated the outcome of CAPD over a period of 25 years at our institution. METHODS: CAPD has been performed in 2301 patients in 25 years. After excluding patients with less than 3 months of follow-up and missing data, we evaluated 1656 patients who started peritoneal dialysis between November 1981 and December 2005. Data for sex, age, primary disease, comorbidities, follow-up duration, cause of death, and cause of technique failure were collected. We also examined data for urea kinetic modeling (UKM), beginning in 1990, and peritonitis episodes, including causative organisms, starting in 1992. RESULTS: Compared to incident patients from 1981-1992, mean age and incidence of ESRD caused by diabetic nephropathy increased in patients from 1993 to 2005. Technique survival after 5 and 10 years was 71.9% and 48.1% respectively. Technique survival was significantly higher in patients who started CAPD after 1992 than in those who started before 1992. Peritonitis was the main reason for technique failure. Overall peritonitis rate was 0.38 episodes per patient-year, with a significant downward trend to 0.29 per patient-year over 10 years, corresponding to a decrease in gram-positive peritonitis. Patient survival after 5 and 10 years was 69.8% and 51.8% respectively. Patient survival improved significantly during 1992-2005 compared to 1981-1992 after adjustment for age, gender, diabetes, and cardiovascular comorbidities [hazard ratio (HR) 0.68, p < 0.01]. Subgroup analysis based on UKM revealed that dialysis adequacy did not affect patient survival. However, diabetes (HR 2.78, p < 0.001), older age (per 1 year: HR 1.06; p < 0.001), serum albumin level (per 1 g/dL: increase, HR 0.52; p < 0.05), and cardiovascular comorbidities (HR 2.32, p < 0.01) were identified as significant risk factors. CONCLUSION: Technique survival has improved due partly to a decrease in peritonitis, which was attributed to a decrease in gram-positive peritonitis. Patient survival has also improved considering increases in aged patients and ESRD caused by diabetes. The mortality rate of CAPD is still high in older, diabetic, malnourished, and cardiovascular diseased patients. A more careful management of higher risk groups will be needed to improve the outcome of CAPD patients in the future.
机译:背景:持续性非卧床腹膜透析(CAPD)是终末期肾脏疾病(ESRD)的既定治疗方法。我们在机构中调查了25年间CAPD的结果。方法:25年内对2301例患者进行了CAPD。在排除随访少于3个月且缺少数据的患者之后,我们评估了1656例在1981年11月至2005年12月之间开始腹膜透析的患者。性别,年龄,原发病,合并症,随访时间,死亡原因的数据,并收集了技术失败的原因。我们还检查了从1990年开始的尿素动力学模型(UKM)和从1992年开始的腹膜炎发作(包括致病菌)的数据。结果:与1981-1992年的发病患者相比,糖尿病肾病引起的ESRD的平均年龄和发病率增加了从1993年至2005年,患者的技术存活率。5年和10年后的技术存活率分别为71.9%和48.1%。 1992年以后开始CAPD的患者的技术存活率显着高于1992年之前开始的患者。腹膜炎是导致技术失败的主要原因。总体腹膜炎发生率为每患者年0.38次,在10年中有显着下降趋势,降至每患者年0.29次,这与革兰氏阳性腹膜炎的减少相对应。 5年和10年后的患者存活率分别为69.8%和51.8%。在调整了年龄,性别,糖尿病和心血管合并症之后,与1981-1992年相比,1992-2005年期间患者的存活率有了显着提高[危险比(HR)0.68,p <0.01]。基于UKM的亚组分析表明,透析充分性不会影响患者生存。但是,糖尿病(HR 2.78,p <0.001),老年(每1年:HR 1.06; p <0.001),血清白蛋白水平(每1 g / dL:增加,HR 0.52; p <0.05)和心血管合并症(HR 2.32,p <0.01)被确定为重要的危险因素。结论:技术存活率提高部分归因于腹膜炎的减少,这归因于革兰氏阳性腹膜炎的减少。考虑到老年患者和由糖尿病引起的ESRD的增加,患者的生存也得到了改善。在老年,糖尿病,营养不良和心血管疾病患者中,CAPD的死亡率仍然很高。将来需要对高风险人群进行更仔细的管理,以改善CAPD患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号